What one share of Axsome Therapeutics holds
We are a fully integrated biopharmaceutical company focused on developing innovative medicines for people impacted by central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and developing differentiated products with a focus on novel mechanisms of action, that have the potential to transform patient outcomes.
Axsome Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $15.25 |
|---|---|
| Profit | −$3.76 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.41 |
| Cash and investments | $6.12 |
| Debt | $3.87 |
| Book value | $1.59 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | — | −$0.66 | — | — | — | — |
| 2015 | — | −$1.02 | $0.00 | −$0.62 | — | — |
| 2016 | — | −$1.42 | $0.01 | −$1.12 | — | — |
| 2017 | — | −$1.27 | $0.00 | −$1.16 | — | — |
| 2018 | — | −$1.15 | $0.00 | −$1.12 | — | — |
| 2019 | — | −$2.01 | $0.00 | −$1.36 | — | $4.84 |
| 2020 | — | −$2.77 | $0.00 | −$2.11 | — | $3.04 |
| 2021 | — | −$3.47 | $0.01 | −$2.89 | — | $0.41 |
| 2022 | $0.00 | −$4.60 | $0.02 | −$2.88 | — | $2.52 |
| 2023 | $5.96 | −$5.27 | $0.01 | −$3.21 | — | $4.03 |
| 2024 | $8.05 | −$5.99 | $0.01 | −$2.69 | — | $1.17 |
| 2025 | $12.83 | −$3.68 | $0.01 | −$1.89 | — | $1.74 |
Common questions about Axsome Therapeutics
How much does one share of Axsome Therapeutics earn?
Over the last 12 months, Axsome Therapeutics lost $3.76 for each share on $15.25 of sales.
Does Axsome Therapeutics pay a dividend?
Axsome Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Axsome Therapeutics’s book value per share?
Axsome Therapeutics’s book value is $1.59 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Axsome Therapeutics have?
Each share of Axsome Therapeutics has $6.12 of cash and investments and $3.87 of debt, as of June 30, 2026.
What is Axsome Therapeutics’s free cash flow per share?
−$1.41 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Axsome Therapeutics bought back shares?
Axsome Therapeutics’s share count rose about 447% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.